In the last trading session, 2.71 million Plus Therapeutics Inc (NASDAQ:PSTV) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $0.33 changed hands at $0.01 or 2.04% during last session, the market valuation stood at $10.65M. PSTV’s last price was a discount, traded about -681.82% off its 52-week high of $2.58. The share price had its 52-week low at $0.24, which suggests the last value was 27.27% up since then.

Plus Therapeutics Inc (NASDAQ:PSTV) trade information

Instantly PSTV was in green as seen at the end of in last trading. With action 13.45%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -71.70%, with the 5-day performance at 13.45% in the green. However, in the 30-day time frame, Plus Therapeutics Inc (NASDAQ:PSTV) is -42.25% down.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.51%. The 2025 estimates are for Plus Therapeutics Inc earnings to increase by 62.82%, but the outlook for the next 5-year period is at 49.89% per year.

PSTV Dividends

Plus Therapeutics Inc is expected to release its next quarterly earnings report in July.

GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 0.7176% or 46648.0 shares worth $68572.0 as of 2024-06-30.

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 35.04 shares estimated at $11406.0 under it, the former controlled 0.11% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.10% of the shares, roughly 32.54 shares worth around $10592.0.